参考文献/References:
[1] YANG H J,SONG D J,SHIM J Y.Mechanism of resistance acquisition and treatment of macrolide-resistant Mycoplasma pneumoniae pneumonia in children[J].Korean J Pediatr,2017,60(6):167-174.
[2] 代继宏,涂金伟,符州.儿童呼吸系统疾病的热点和难点问题及研究进展[J].中华实用儿科临床杂志,2017,32(16):1205-1209.
[3] ZHANG Y Y,ZHOU Y L,LI S X,et al.The clinical characteristics and predictors of refractory Mycoplasma pneumoniae pneumonia in Children[J].PLoS One,2016,11(5):e0156465.
[4] HAN S,MALLAMPALLI R K.The role of surfactant in lung disease and host defense against pulmonary infections[J].Ann Am Thorac Soc,2015,12(5):765-774.
[5] GAUNSBAEK M Q,RASMUSSEN K J,BEERS M F,et al.Lung surfactant protein D(SP-D) response and regulation during acute and chronic lung injury[J].Lung,2013,191(3):295-303.
[6] SHIN J E,CHEON B R,SHIM J W,et al.Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma[J].Korean J Pediatr,2014,57(6):271-277.
[7] 中华医学会儿科学分会呼吸学组,《中华实用儿科临床杂志》编辑委员会.儿童肺炎支原体肺炎诊治专家共识(2015年版)[J].中华实用儿科临床杂志,2015,30(17):1304-1308.
[8] 张华.不同病原体感染肺炎患儿支气管肺泡灌洗液中肺表面活性物质相关蛋白的表达[J].新乡医学院学报,2017,34(6):510-512.
[9] SHIN J E,CHEON B R,SHIM J W,et al.Increased risk of refractory Mycoplasma pneumoniae pneumonia in children with atopic sensitization and asthma[J].Korean J Pediatr,2014,57(6):271-277.
[10] 温顺航,张海邻,李昌崇.儿童肺炎支原体肺炎的影像学表现[J].中华实用儿科临床杂志,2016,31(16):1272-1274.
[11] BAE C W,CHUNG S H,CHOI Y S.Development of a synthetic surfactant using a surfactant protein-c peptide analog:in vitro studies of surface physical properties[J].Yonsei Med J,2016,57(1):203-208.
[12] SARKER M,JACKMAN D,BOOTH V.Lung surfactant protein a(SP-a) interactions with model lung surfactant lipids and an SP-B fragment[J].Biochemistry,2011,50(22):4867-4876.
[13] 高阳,刘冬云,孔祥斌,等.环氧合酶2抑制剂对高氧环境下新生大鼠肺组织肺表面活性物质相关蛋白B、转化生长因子-β1表达的影响[J].中华实用儿科临床杂志,2016,31(14):1081-1085.
[14] MALCHAREK S,HINZ A,HILTERHAUS L,et al.Multilayer structures in lipid monolayer films containing surfactant protein C:effects of cholesterol and POPE[J].Biophys J,2005,88(4):2638-2649.
[15] 王晶,梅花.肺表面活性蛋白B、C与新生儿肺疾病关系的研究进展[J].中国新生儿科杂志,2015,30(5):387-389.
[16] 刘娇,陈德昌.肺表面活性蛋白的研究进展[J].中华实用儿科临床杂志,2014,22(12):878-882.
相似文献/References:
[1]张桂欣.甲泼尼龙联合阿奇霉素序贯疗法治疗儿童难治性肺炎支原体肺炎疗效观察[J].新乡医学院学报,2020,37(10):964.[doi:10.7683/xxyxyxb.2020.10.014]
ZHANG Guixin.Effect of methylprednisolone combined with azithromycin sequential therapy in the treatment of refractory mycoplasma pneumoniae pneumonia in children[J].Journal of Xinxiang Medical University,2020,37(6):964.[doi:10.7683/xxyxyxb.2020.10.014]
[2]徐素玲,李 政,张 成.肺炎支原体肺炎患儿血清和支气管肺泡灌洗液中肺表面活性蛋白A、肺表面活性蛋白D和Toll样受体2水平变化及临床意义[J].新乡医学院学报,2018,35(7):605.[doi:10.7683/xxyxyxb.2018.07.014]
XU Su-ling,LI Zheng,ZHANG Cheng.Clinical significance of the changes in pulmonary surfactant protein A,surfactant protein D and Toll- like receptor 2 in serum and bronchoalveolar lavage fluid in children with mycoplasma pneumoniae pneumonia[J].Journal of Xinxiang Medical University,2018,35(6):605.[doi:10.7683/xxyxyxb.2018.07.014]